181 related articles for article (PubMed ID: 12801832)
1. Erythropoietin therapy: need for rationality and active surveillance.
Cazzola M
Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
[No Abstract] [Full Text] [Related]
2. [Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo].
Luraschi A; Montanara S; Fedeli P; Buscaglia P; Fossati O; Cozzi S; Castello A
Recenti Prog Med; 2008 May; 99(5):255-7. PubMed ID: 18581968
[TBL] [Abstract][Full Text] [Related]
3. Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta.
Manenti L; Vaglio A
Nephrol Dial Transplant; 2007 May; 22(5):1465-7. PubMed ID: 17337465
[No Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
Rossert J; Casadevall N
Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
6. Pure red-cell aplasia and recombinant erythropoietin.
Gershon SK; Luksenburg H; Coté TR; Braun MM
N Engl J Med; 2002 May; 346(20):1584-6; author reply 1584-6. PubMed ID: 12015400
[No Abstract] [Full Text] [Related]
7. NCCN: New applications for erythropoietin.
Demetri GD
Cancer Control; 2001; 8(6 Suppl 2):72-6. PubMed ID: 11760562
[No Abstract] [Full Text] [Related]
8. A clinical review of antibody-mediated pure red cell aplasia.
Vogel S; Rossert J
Nephrol Nurs J; 2005; 32(1):17-8, 23-6; quiz 27. PubMed ID: 15787081
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
Grzegorzewska AE; Sucharzewska-Tomczak M
Pol Merkur Lekarski; 2004 Oct; 17(100):407-9. PubMed ID: 15690716
[TBL] [Abstract][Full Text] [Related]
10. Anemia of chronic kidney disease.
Singh AK
Clin J Am Soc Nephrol; 2008 Jan; 3(1):3-6. PubMed ID: 18077779
[No Abstract] [Full Text] [Related]
11. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
Opatrný K
Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
[TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin: indications and measurement].
Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
[TBL] [Abstract][Full Text] [Related]
13. Epoetin-induced pure red cell aplasia successfully treated with androgens.
Sánchez de la Nieta MD; Caparrós G; Rivera F
J Nephrol; 2006; 19(2):220-1. PubMed ID: 16736425
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced autoimmune red-cell aplasia.
Bunn HF
N Engl J Med; 2002 Feb; 346(7):522-3. PubMed ID: 11844855
[No Abstract] [Full Text] [Related]
15. Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland.
Sułowicz W; Bentkowski W; Stompór T; Gross J; Biłyk A; Rudzki Z
Przegl Lek; 2006; 63(9):810-4. PubMed ID: 17479877
[TBL] [Abstract][Full Text] [Related]
16. Treatment of anaemia with rHuEpo in patients with MDS.
Casadevall N
Med Oncol; 1998 Aug; 15 Suppl 1():S35-7. PubMed ID: 9785335
[No Abstract] [Full Text] [Related]
17. [What are the aims and targets of renal anemia therapy?].
Eckardt KU
Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
[No Abstract] [Full Text] [Related]
18. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge.
Smalling R; Foote M; Molineux G; Swanson SJ; Elliott S
Biotechnol Annu Rev; 2004; 10():237-50. PubMed ID: 15504708
[TBL] [Abstract][Full Text] [Related]
19. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):481-9. PubMed ID: 15792923
[TBL] [Abstract][Full Text] [Related]
20. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]